In this study, it was demonstrated that the inhibition of GSK3β greatly suppressed the invasiveness of NSCLC cells, regardless of the cancer type, and this result supports the prognostic value and tumor promoter role of GSK3β in lung cancer. This evidence concerns the gene GSK3B and non-small cell lung carcinoma.